Artikler med mandater om offentlig tilgang - Christine VauthierLes mer
Ikke tilgjengelig noe sted: 1
Protein–nanoparticle interactions evaluation by immunomethods: Surfactants can disturb quantitative determinations
C Fornaguera, G Caldero, C Solans, C Vauthier
European Journal of Pharmaceutics and Biopharmaceutics 94, 284-290, 2015
Mandater: Government of Spain
Tilgjengelige et eller annet sted: 11
Interactions of PLGA nanoparticles with blood components: protein adsorption, coagulation, activation of the complement system and hemolysis studies
C Fornaguera, G Calderó, M Mitjans, MP Vinardell, C Solans, C Vauthier
Nanoscale 7 (14), 6045-6058, 2015
Mandater: Government of Spain
Oral administration of paclitaxel with pegylated poly (anhydride) nanoparticles: permeability and pharmacokinetic study
V Zabaleta, G Ponchel, H Salman, M Agüeros, C Vauthier, JM Irache
European Journal of Pharmaceutics and Biopharmaceutics 81 (3), 514-523, 2012
Mandater: Government of Spain
Effects of block copolymer properties on nanocarrier protection from in vivo clearance
SM D'Addio, W Saad, SM Ansell, JJ Squiers, DH Adamson, ...
Journal of Controlled Release 162 (1), 208-217, 2012
Mandater: US National Institutes of Health
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor
S Valetti, F Maione, S Mura, B Stella, D Desmaele, M Noiray, J Vergnaud, ...
Journal of Controlled Release 192, 29-39, 2014
Mandater: European Commission, Government of Italy
Mucoadhesive properties of low molecular weight chitosan-or glycol chitosan-and corresponding thiomer-coated poly (isobutylcyanoacrylate) core-shell nanoparticles
C Palazzo, G Trapani, G Ponchel, A Trapani, C Vauthier
European Journal of Pharmaceutics and Biopharmaceutics 117, 315-323, 2017
Mandater: Government of Italy
Artificial oxygen carrier based on polysaccharides–poly (alkylcyanoacrylates) nanoparticle templates
C Chauvierre, R Manchanda, D Labarre, C Vauthier, MC Marden, ...
Biomaterials 31 (23), 6069-6074, 2010
Mandater: National Institute of Health and Medical Research, France
Controlled release, intestinal transport, and oral bioavailablity of paclitaxel can be considerably increased using suitably tailored pegylated poly (anhydride) nanoparticles
P Calleja, S Espuelas, C Vauthier, G Ponchel, JM Irache
Journal of Pharmaceutical Sciences 104 (9), 2877-2886, 2015
Mandater: Government of Spain
Defining endocytic pathways of Fucoidan-coated PIBCA nanoparticles from the design of their surface architecture
MCB Lira-Nogueira, VP Gibson, V Nicolas, NS Santos-Magalhães, ...
Pharmaceutical Research 39 (6), 1135-1150, 2022
Mandater: Agence Nationale de la Recherche
Obtaining nonspherical poly (alkylcyanoacrylate) nanoparticles by the stretching method applied with a marketed water-soluble film
C Palazzo, G Ponchel, JJ Vachon, S Villebrun, F Agnely, C Vauthier
International Journal of Polymeric Materials and Polymeric Biomaterials 66 …, 2017
Mandater: Government of Italy
Understanding nanomedicine size and biological response dependency: what is the relevance of previous relationships established on only batch-mode DLS-measured sizes?
E Eleamen Oliveira, M Barendji, C Vauthier
Pharmaceutical Research 37, 1-16, 2020
Mandater: Agence Nationale de la Recherche
Oral administration of paclitaxel with pegylated poly (anhydride) nanoparticles: permeability and pharmacokinetic study
M Agüeros, V Zabaleta, C Vauthier, G Ponchel, HH Salman, JM Irache
Elsevier, 2012
Mandater: Government of Spain
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram